• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒杆菌神经毒素治疗帕金森病自主症状的应用:最新综述。

Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.

机构信息

Department of Neurology, Michigan State University, East Lansing, MI 48824-7015, USA.

出版信息

Toxins (Basel). 2021 Mar 19;13(3):226. doi: 10.3390/toxins13030226.

DOI:10.3390/toxins13030226
PMID:33808714
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8003355/
Abstract

Parkinson's disease is the most common age-related motoric neurodegenerative disease. In addition to the cardinal motor symptoms of tremor, rigidity, bradykinesia, and postural instability, there are numerous non-motor symptoms as well. Among the non-motor symptoms, autonomic nervous system dysfunction is common. Autonomic symptoms associated with Parkinson's disease include sialorrhea, hyperhidrosis, gastrointestinal dysfunction, and urinary dysfunction. Botulinum neurotoxin has been shown to potentially improve these autonomic symptoms. In this review, the varied uses of botulinum neurotoxin for autonomic dysfunction in Parkinson's disease are discussed. This review also includes discussion of some additional indications for the use of botulinum neurotoxin in Parkinson's disease, including pain.

摘要

帕金森病是最常见的与年龄相关的运动神经元退行性疾病。除了震颤、僵直、运动迟缓、姿势不稳等主要运动症状外,还有许多非运动症状。在非运动症状中,自主神经系统功能障碍较为常见。与帕金森病相关的自主症状包括流涎、多汗、胃肠功能障碍和排尿功能障碍。肉毒毒素已被证明可能改善这些自主症状。本文综述了肉毒毒素在帕金森病自主神经功能障碍中的多种用途。本文还讨论了肉毒毒素在帕金森病中的一些其他适应证,包括疼痛。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b2c/8003355/39e656c9bb28/toxins-13-00226-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b2c/8003355/c0d7780acede/toxins-13-00226-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b2c/8003355/39e656c9bb28/toxins-13-00226-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b2c/8003355/c0d7780acede/toxins-13-00226-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b2c/8003355/39e656c9bb28/toxins-13-00226-g002.jpg

相似文献

1
Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.肉毒杆菌神经毒素治疗帕金森病自主症状的应用:最新综述。
Toxins (Basel). 2021 Mar 19;13(3):226. doi: 10.3390/toxins13030226.
2
Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal.肉毒杆菌神经毒素在帕金森病中的应用:批判性评估
Toxins (Basel). 2021 Jan 25;13(2):87. doi: 10.3390/toxins13020087.
3
Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea.肉毒杆菌毒素治疗自主神经功能紊乱:局灶性多汗症和流涎症。
Semin Neurol. 2016 Feb;36(1):20-8. doi: 10.1055/s-0035-1571214. Epub 2016 Feb 11.
4
[Management of autonomic dysfunction in Parkinson's disease].[帕金森病自主神经功能障碍的管理]
Rev Neurol. 2015 Apr 16;60(8):355-64.
5
Use of botulinum toxin in Parkinson's disease.肉毒毒素在帕金森病中的应用。
Parkinsonism Relat Disord. 2019 Feb;59:57-64. doi: 10.1016/j.parkreldis.2018.12.002. Epub 2018 Dec 11.
6
An update on the use of botulinum toxin therapy in Parkinson's disease.关于肉毒毒素治疗帕金森病的最新进展。
Curr Neurol Neurosci Rep. 2015 Jan;15(1):511. doi: 10.1007/s11910-014-0511-3.
7
Non-motor symptoms in Parkinson's disease.帕金森病的非运动症状
J Neurol. 2009 Aug;256 Suppl 3:293-8. doi: 10.1007/s00415-009-5240-1.
8
[Disorders of autonomic regulation in Parkinson syndrome].[帕金森综合征中的自主神经调节障碍]
Fortschr Neurol Psychiatr. 1995 May;63(5):194-205. doi: 10.1055/s-2007-996616.
9
Managing autonomic dysfunction in Parkinson's disease: a review of emerging drugs.帕金森病自主神经功能障碍的管理:新兴药物的综述。
Expert Opin Emerg Drugs. 2020 Mar;25(1):37-47. doi: 10.1080/14728214.2020.1729120. Epub 2020 Feb 20.
10
Sialorrhea in Parkinson's Disease.帕金森病中的流涎。
Toxins (Basel). 2020 Oct 31;12(11):691. doi: 10.3390/toxins12110691.

引用本文的文献

1
Rhapontin activates nuclear factor erythroid 2-related factor 2 to ameliorate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced gastrointestinal dysfunction in Parkinson's disease mice.rhapontin激活核因子红细胞2相关因子2以改善1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的帕金森病小鼠胃肠功能障碍。
World J Gastroenterol. 2025 Apr 21;31(15):104875. doi: 10.3748/wjg.v31.i15.104875.
2
Guidelines for the Use of Botulinum Toxin in Otolaryngology From the Korean Society of Laryngology, Phoniatrics and Logopedics Guideline Task Force.韩国耳鼻喉科学会、语音病理学与语言治疗学会指南工作组发布的肉毒杆菌毒素在耳鼻喉科应用指南。
Clin Exp Otorhinolaryngol. 2023 Nov;16(4):291-307. doi: 10.21053/ceo.2023.00458. Epub 2023 Oct 25.
3

本文引用的文献

1
An overview of pain in Parkinson's disease.帕金森病中的疼痛概述。
Clin Park Relat Disord. 2019 Nov 28;2:1-8. doi: 10.1016/j.prdoa.2019.11.004. eCollection 2020.
2
Sex Disparities in Autonomic Symptom Treatment in Parkinson's Disease.帕金森病自主神经症状治疗中的性别差异
Mov Disord Clin Pract. 2020 Jul 2;7(6):718-719. doi: 10.1002/mdc3.12997. eCollection 2020 Aug.
3
Management of Visual Dysfunction in Patients with Parkinson's Disease.帕金森病患者视觉功能障碍的管理。
Pharmacological Treatment of Tremor in Parkinson's Disease Revisited.
帕金森病震颤的药物治疗再探。
J Parkinsons Dis. 2023;13(2):127-144. doi: 10.3233/JPD-225060.
J Parkinsons Dis. 2020;10(s1):S49-S56. doi: 10.3233/JPD-202103.
4
Parkinson's disease: etiopathogenesis and treatment.帕金森病:病因发病机制与治疗。
J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):795-808. doi: 10.1136/jnnp-2019-322338. Epub 2020 Jun 23.
5
Management of Pain in Parkinson's Disease.帕金森病疼痛的管理。
J Parkinsons Dis. 2020;10(s1):S37-S48. doi: 10.3233/JPD-202069.
6
Parkinson's Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization.帕金森病:用于诊断、疾病风险评估和药物治疗个体化的现有临床及有前景的组学检测方法
Diagnostics (Basel). 2020 May 25;10(5):339. doi: 10.3390/diagnostics10050339.
7
Managing autonomic dysfunction in Parkinson's disease: a review of emerging drugs.帕金森病自主神经功能障碍的管理:新兴药物的综述。
Expert Opin Emerg Drugs. 2020 Mar;25(1):37-47. doi: 10.1080/14728214.2020.1729120. Epub 2020 Feb 20.
8
Diagnosis and Treatment of Parkinson Disease: A Review.帕金森病的诊断与治疗:综述。
JAMA. 2020 Feb 11;323(6):548-560. doi: 10.1001/jama.2019.22360.
9
State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson's disease.帕金森病自主神经功能障碍的最新药物治疗。
Expert Opin Pharmacother. 2020 Mar;21(4):445-457. doi: 10.1080/14656566.2020.1713097. Epub 2020 Jan 20.
10
Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease.动物模型在促进对帕金森病疼痛的理解和治疗方面的潜力。
NPJ Parkinsons Dis. 2020 Jan 6;6:1. doi: 10.1038/s41531-019-0104-6. eCollection 2020.